Disease presentation and surgical treatment of patients with foreign-body granulomas and ASIA syndrome: case series

Background The result of illicit polymer injection is chronic inflammation with foreign-body granuloma (FBG) formation. Treatment can be divided into medical and surgical. Some patients develop severe complications with need surgical treatment. This study aims to describe patients who underwent surgical removal of the FBGs and autoimmune/inflammatory syndrome induced by adjuvants (ASIA); additionally, we evaluated the quality of life after surgery.

Methods In this retrospective single-center study, the authors examined data of patients who underwent surgical removal of FBG caused by illicit polymer injection for cosmetic purposes and confirmed ASIA from 2015 to 2020 by three different surgical approaches. Descriptive summary statistics were reported on patient demographics, presenting symptoms and clinical examination features, treatment strategies, histopathology reports and quality of life.

Results The cohort included 11 female patients with FBGs and ASIA. The most affected anatomical zones were the combination of gluteal region, thighs and legs (40%); and thighs with legs (20%). Main presentation was: skin hyperpigmentation (90.9%), skin induration (63.6%), chronic fatigue (63.6%), and ulcers (36.4%). Surgical modalities consisted of: ultrasonic-assisted liposuction in four patients (36.4%); open en bloc excision and primary closure in four patients (36.4%); and open en bloc excision and microsurgical reconstruction in three patients (27.2%). The postoperative quality of life visual analog scale score was 83.9.

Conclusions ASIA treatment represents a challenge for the plastic surgeon. Adequate surgical treatment emphasizing, when possible, the total or near-total resection of the FBG must be performed to improve ASIA evolution.

Keywords

Quality of life - Granuloma, foreign-body - Polymers - Xenobiotics

Publikationsverlauf

Eingereicht: 25. Oktober 2020

Angenommen: 25. Mai 2021

Artikel online veröffentlicht:
21. März 2022

• REFERENCES

• 1 Miyoshi K, Miyamura T, Kobayashi T. et al. Hypergammaglobulinemia by prolonged adjuvanticity in men: disorders developed after augmentation mammoplasty. J Keio Med Soc 1964; 2122: 9-14
• 2 Baldwin Jr CM, Kaplan EN. Silicone-induced human adjuvant disease?. Ann Plast Surg 1983; 10: 270-3
• 3 Cardenas-Camarena L. Managing the mammary gland infiltrated with foreign substances: different surgical alternatives. Ann Plast Surg 2009; 62: 621-6
• 4 Ahmed U, Freeman A, Kirkham A. et al. Self injection of foreign materials into the penis. Ann R Coll Surg Engl 2017; 99: e78-82
• 5 Martinez-Villarreal AA, Asz-Sigall D, Gutierrez-Mendoza D. et al. A case series and a review of the literature on foreign modelling agent reaction: an emerging problem. Int Wound J 2017; 14: 546-54
• 6 Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P. et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld’s syndrome). Lupus 2012; 21: 128-35
• 7 Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4-8
• 8 Vera-Lastra O, Medina G, Cruz-Dominguez MP. et al. Autoimmune/inflammatory syndrome induced by mineral oil: a health problem. Clin Rheumatol 2018; 37: 1441-8
• 9 Cohen Tervaert JW. Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld’s syndrome): a new flame. Autoimmun Rev 2018; 17: 1259-64
• 10 Vera-Lastra O, Hernadez PB, Sanchez-Rodriguez A. et al. AB0991 Prevalence of fibromyalgia and depression in patients with autoimmune/inflammatory syndrome induced by adjuvants compared to patients with systemic sclerosis. Ann Rheum Dis 2017; 76 Suppl 2 1401
• 11 Petry T, Bury D, Fautz R. et al. Review of data on the dermal penetration of mineral oils and waxes used in cosmetic applications. Toxicol Lett 2017; 280: 70-8
• 12 Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P. et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol 2013; 9: 361-73
• 13 Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982; 69: 1388-92
• 14 Dagan A, Kogan M, Shoenfeld Y. et al. When uncommon and common coalesce: adult onset Still’s disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA). Clin Rheumatol 2016; 35: 1643-8
• 15 Grippaudo FR, Spalvieri C, Rossi A. et al. Ultrasound-assisted liposuction for the removal of siliconomas. Scand J Plast Reconstr Surg Hand Surg 2004; 38: 21-6
• 16 Bassetto F, Abatangelo S, Masetto L. et al. Ultrasound-assisted liposuction as a safe and effective method for the removal of siliconomas. Aesthetic Plast Surg 2012; 36: 220-2
• 17 Park TH, Seo SW, Kim JK. et al. Clinical outcome in a series of 173 cases of foreign body granuloma: improved outcomes with a novel surgical technique. J Plast Reconstr Aesthet Surg 2012; 65: 29-34
• 18 EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
• 19 Colaris MJL, de Boer M, van der Hulst RR. et al. Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res 2017; 65: 120-8
• 20 Zandi I. Removal of soft tissue injected with liquid silicone with an ultrasound-suction system. Plast Reconstr Surg 2001; 107: 1077
• 21 Lee JM, Kim YJ. Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg 2015; 42: 232-9
• 22 Schenone GE. Bioethical considerations. In: Schenone G. Injection-induced breast siliconomas. Cham: Springer; 2020: 271-88
• 23 Janssen B, Szende A. Population Norms for the EQ-5D. In: Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014: 19-30
• 24 Mendoza JL, Tarriba JT, Reyes AI. Microsurgical management of severe human adjuvant disease due to mineral oil injection. Int Microsurg J 2020; 4: 1